Mania After Venlafaxine Withdrawal in a Patient with Generalized Anxiety Disorder
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Stein et al. and Montgomery et al., discontinuation symptoms in patients switched to placebo were similar to those of patients maintained on agomelatine.
“In Stein et al. [107] and in Montgomery et al. [108], discontinuation symptoms in patients switched to placebo were similar to those of patients maintained on agomelatine.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [107]
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914 · see citing works
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455 · see citing works
The Bech-Rafaelsen Mania Scale in Clinical Trials of Therapies for Bipolar Disorder
Bech, P. (2002) · CNS Drugs · doi:10.2165/00023210-200216010-00004 · Cited by 102 · see citing works
Antidepressant-Withdrawal Mania: A Critical Review and Synthesis of the Literature
Andrade, C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0716 · Cited by 49 · see citing works
A Case Report of Mania Related to Discontinuation of Bupropion Therapy for Smoking Cessation
Michael, N., Erfurth, A., & Arolt, V. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0220e · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works
Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209 · see citing works
Narayan, V., & Haddad, P. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359094 · Cited by 48 · see citing works
Crossroads of Pain and Addiction:
Bailey, J. A., Hurley, R. W., & Gold, M. S. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00982.x · Cited by 42 · see citing works
Peritogiannis, V., Antoniou, K., Mouka, V., Mavreas, V. G., & Hyphantis, T. N. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089841 · Cited by 22 · see citing works
Substance-Related Disorders in Adults
Leikin, J. B. (2007) · Disease-a-Month · doi:10.1016/j.disamonth.2007.04.001 · Cited by 14 · see citing works
Kassm, S. A., & Naja, W. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.080 · Cited by 3 · see citing works
Antidepressant Efficacy of Escitalopram in Major Depressive Disorder
Kirino, E. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_30 · Cited by 3 · see citing works
Pain and Addictive Disorders: Challenge and Opportunity
Covington, E. C. (2008) · Elsevier eBooks · doi:10.1016/b978-032304184-3.50046-7 · Cited by 1 · see citing works
Covington, E. C., & Bailey, J. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-323-08340-9.00050-5
Current awareness: Pharmacoepidemiology and drug safety
(2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1383
Zhao, A., Qiao, J., Kuang, R., Chen, Z., Tan, Y., Zhu, M., & Zhou, G. (2026) · BMC Genomics · doi:10.1186/s12864-026-12979-2
- Authors
- Khazaal, Y.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Khazaal, Yasser
- ORCID
- Khazaal, Yasser
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2007-02
- Volume
- 41
- Issue
- 2
- Pages
- 359-360
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2051443522
- Cited by
- 13
- References
- 5
- Citations by year
- 2026: 1 · 2020: 1 · 2018: 2 · 2016: 1 · 2013: 1
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- mania, venlafaxine, drug withdrawal, generalized anxiety disorder, antidepressant discontinuation, bipolar disorder
- MeSH terms
- Venlafaxine Hydrochloride, Adult, Anxiety Disorders, Bipolar Disorder, Cyclohexanols, Humans, Male, Substance Withdrawal Syndrome, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
